6.7 Percent of U.S. Adults Cannot Use Automatic BP Devices Due to Arm Size
By Lori Solomon HealthDay Reporter
FRIDAY, Sept. 6, 2024 -- An estimated 6.7 percent of U.S. adults cannot use popular automatic blood pressure devices due to arm circumference, according to a research letter published online Sept. 5 in Hypertension to coincide with the American Heart Association Hypertension 2024 Scientific Sessions, held from Sept. 5 to 8 in Chicago.
Eileen Kaur, from Howard High School in Ellicott City, Maryland, and colleagues evaluated the cuff sizes in 10 popular blood pressure devices from Amazon's Automatic Blood Pressure Category and quantified the coverage of arm circumference ranges among 13,826 adults participating in the National Health and Nutrition Examination Survey (2015 to 2020).
The researchers found that of the 10 evaluated devices, nine offered cuff sizes covering arm circumferences from 22 to 42 cm and one offered sizes from 22 to 40 cm. An estimated 6.7 percent of U.S. adults (corresponding to 17.3 million adults) could not use these devices "as is" due to arm circumferences <22 cm (0.3 percent [0.8 million], including 32.3 percent with hypertension) or >42 cm (6.4 percent [16.5 million], including 67.3 percent with hypertension). Black adults (11.8 percent) had a higher proportion not covered by these devices than other racial/ethnic groups (6.6, 5.2, and 1.8 percent for White, Hispanic, and Asian adults, respectively). A similar proportion of women (6.9 percent) and men (6.6 percent) were not eligible for these devices.
"To increase equity, manufacturers should prioritize the development and affordable sale of blood pressure measuring devices that accommodate arm circumferences greater than 42 centimeters, and health care professionals should measure patients' arm circumferences to help them select an appropriate cuff size when purchasing a home blood pressure device," senior author Kunihiro Matsushita, M.D., Ph.D., from the Johns Hopkins Bloomberg School of Public Health in Baltimore, said in a statement.
One author disclosed ties to Fukuda Denshi.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted September 2024
Read this next
Lorundrostat Beneficial for BP Reduction in Uncontrolled Hypertension
WEDNESDAY, April 30, 2025 -- For patients with uncontrolled and treatment-resistant hypertension, lorundrostat is associated with greater reductions in blood pressure than...
Declining Childhood Vaccination May Increase Risk for Vaccine-Preventable Infections
WEDNESDAY, April 30, 2025 -- Declining childhood vaccination rates may increase outbreaks of eliminated vaccine-preventable infections within the United States, leading to a...
AACR: Incidence-Based Mortality Dropping for Young Women With Breast Cancer
TUESDAY, April 29, 2025 -- Incidence-based mortality (IBM) declined from 2010 to 2020 among women aged 20 to 49 years diagnosed with breast cancer, according to a study presented...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.